Afluria 2017 - 2018 Flu Vaccine 45 mcg / 0.5 mL Indicated For People 5 Years of Age and Above Multiple Dose Vial 5 mL Seqirus 33332011710

Afluria 2017 - 2018 Flu Vaccine 45 mcg / 0.5 mL Indicated For People 5 Years of Age and Above Multiple Dose Vial 5 mL Seqirus 33332011710

TERMS & CONDITIONS FOR PURCHASING INJECTABLES & MEDICATIONS : 1- REGULATIONS ON PURCHASE OF INJECTABLES & MEDICATIONS VARY FROM STATE TO STATE . IT IS THE PURCHASER'S RESPONSIBILITY TO KNOW AND COMPLY WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE. 2- INJECTABLES & MEDICATIONS WOULD BE SOLD ONLY TO QUALIFIED CUSTOMERS ( PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES , DENTAL OFFICES , HEALTH CARE PROVIDERS , .... ) WITH VALID MEDICAL LICENSE. 3- ORDERS INCLUDING PURCHSE OF INJECTABLES & MEDICATIONS WOULD BE PROCESSED AFTER VERIFICATION OF PURCHASER'S VALID MEDICAL LICENSE TO BE EMAILED AS AN ATTACHMENT TO : ADMIN@ALLMEDTECH.COM OR FAXED TO 323-782-0985 )

Manufacturer # 33332011710 Brand Afluria® 2017 - 2018 Manufacturer Seqirus USA Inc Application Flu Vaccine Container Type Multiple Dose Vial Dosage Form Injection Generic Drug Code 43463 NDC Number 33332-0117-10 Storage Requirements Requires Refrigeration Strength 45 mcg / 0.5 mL Type Intramuscular User Indicated For People 5 Years of Age and Above Volume 5 mL

Features

AFLURIA is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B present in the vaccine AFLURIA is approved for use in persons 5 years of age and older AFLURIA is standardized according to USPHS requirements for the 2017-2018 influenza season and is formulated to contain 45 mcg hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the three influenza strains recommended for the 2017-2018 Northern Hemisphere influenza season: A/Singapore/GP1908/2015 (H1N1), IVR-412 180A, A/Hong Kong/4801/2014 (H3N2), NYMC X-263B, and B/Brisbane/46/2015